NCT01938404View on ClinicalTrials.gov

Octaplas Adult TTP Trial

TerminatedOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

June 6, 2017

Primary Completion Date

August 2, 2017

Study Completion Date

August 2, 2017

Conditions

Thrombotic Thrombocytopenic Purpura

Interventions

BIOLOGICAL

Octaplas

Octoplas infusion solution for IV administration

DRUG

Standard Plasma

Plasma given as replacement fluid

Trial Locations (2)

11030

Octapharma Study Site, Manhasset

14642

Octapharma Study Site, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Octapharma

INDUSTRY

NCT01938404 - Octaplas Adult TTP Trial | Biotech Hunter | Biotech Hunter